External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26

Evelyn Herrmann*, Diana Naehrig, Manfred Sassowsky, Martin Bigler, Jeroen Buijsen, Ilja Ciernik, Daniel Zwahlen, Alessandra Franzetti Pellanda, Andreas Meister, Peter Brauchli, Simona Berardi, Erika Kuettel, Jean-Francois Dufour, Daniel M. Aebersold, Swiss Grp Clinical Canc Res SAKK

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number12
Number of pages9
JournalRadiation Oncology
Volume12
DOIs
Publication statusPublished - 2017

Keywords

  • Hepatocellular carcinoma
  • Conformal radiotherapy
  • Liver
  • Radiation toxicity
  • STEREOTACTIC BODY RADIOTHERAPY
  • CONFORMAL RADIATION-THERAPY
  • TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
  • INDUCED LIVER-DISEASE
  • TRANSARTERIAL CHEMOEMBOLIZATION
  • NORMAL TISSUE
  • INTRAHEPATIC MALIGNANCIES
  • RADIOFREQUENCY ABLATION
  • HEPATOBILIARY CANCERS
  • MRECIST RESPONSES

Cite this

Herrmann, E., Naehrig, D., Sassowsky, M., Bigler, M., Buijsen, J., Ciernik, I., Zwahlen, D., Pellanda, A. F., Meister, A., Brauchli, P., Berardi, S., Kuettel, E., Dufour, J-F., Aebersold, D. M., & Swiss Grp Clinical Canc Res SAKK (2017). External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26. Radiation Oncology, 12, [12]. https://doi.org/10.1186/s13014-016-0745-0